The pregnenolone X receptor (PXR), a new member of the nuclear hormone receptor superfamily, was recently demonstrated to mediate glucocorticoid agonist and antagonist activation of a hormone response element spaced by three nucleotides (DR-3) within the rat CYP3A23 promoter. Because many other steroids and xenobiotics can up-regulate CYP3A23 expression, we determined whether some of these other regulators used PXR to activate the CYP3A23 DR-3. Transient cotransfection of LLC-PK1 cells with (CYP3A23) 2 -tk-CAT and mouse PXR demonstrated that the organochlorine pesticides transnonachlor and chlordane and the nonplanar polychlorinated biphenyls (PCBs) each induced the CYP3A23 DR-3 element, and this activation required PXR. Additionally, this study found that PXR is activated to induce (CYP3A23) 2 -tk-CAT by antihormones of several steroid classes including the antimineralocorticoid spironolactone and the antiandrogen cyproterone acetate. These studies reveal that PXR is involved in the induction of CYP3A23 by pharmacologically and structurally distinct steroids and xenobiotics. Moreover, PXR-mediated PCB activation of the (CYP3A23) 2 -tk-CAT may serve as a rapid assay for effects of nonplanar PCBs.
The human and rat CYP3A forms are induced by numerous steroidal hormones; a hallmark feature is their nonclassical induction by glucocorticoids . Characteristics of this nonclassical induction include requirements for pharmacological amounts of steroid to induce CYP3A as well as the paradoxical induction of CYP3A23 1 by both the glucocorticoid agonist dexamethasone and the antiglucocorticoids PCN and RU486 (Kocarek et al., 1995) . We previously hypothesized that other classes of antihormones might share regulatory characteristics and induce CYP3A as well (Kocarek et al., 1995) . Further studies revealed that antihormone representatives of many of the major steroid classes, including the antimineralocorticoid spironolactone and the antiandrogen cyproterone acetate, were each able to induce hepatic CYPA3A in rat and human hepatocytes (Kocarek et al., 1995) and led us to speculate about a common regulatory factor (Kocarek et al., 1995) . Additionally, CYP3A23 is also induced by important environmental xenobiotics including organochlorine pesticides (e.g., transnonachlor and chlordane), and some polychlorinated biphenyls, particularly those with ortho-chlorines (Schuetz et al., 1986) .
A new member of the nuclear hormone receptor superfamily, the PXR that mediates glucocorticoid agonist and glucocorticoid antagonist induction of the CYP3A23 gene has recently been identified (Kliewer et al., 1998) . The glucocorticoid agonist or antagonist activated PXR:RXR heterodimer bound to a hormone response element, an AGTTCAtgaAGT-TCA direct repeat with a three-nucleotide spacer (DR-3), in the 5Ј-flanking region of the CYP3A23 gene to induce its transcription. A number of other hormones (e.g., pregnenolone and progesterone) were also identified as activators of PXR. We have tested the hypothesis that other classes of steroidal antihormones and environmental chemicals might represent additional activators of PXR. We found that transcriptional activation of the CYP3A23 DR-3 hormone reThis work was supported by National Institute of Health Research Grants ES08658 (E.G.S.), ES05851 (J.D.S.), P30-CA21765 (E.G.S., J.D.S.) and by the American Lebanese Syrian Associated Charities (ALSAC).
1 CYP3A23 refers to the major dexamethasone, PCN and phenobarbital inducible form of CYP3A in rat liver (Komori and Oda, 1994) which is now recognized to be CYP3A23, not CYP3A1. The CYP3A 5Јflanking regulatory sequence previously identified as CYP3A1 (Burger et al., 1992; Quattrochi et al., 1995; Kliewer et al., 1998) is in fact CYP3A23 (Nelson et al., 1993; Barwick et al., 1996) . Likewise, because the CYP3A1 cDNA probe used in all previous publications of CYP3A regulation cannot distinguish between CYP3A1 and CYP3A23, we refer to the CYP3A in these publications as CYP3A23.
sponse element by many of these structurally diverse compounds is mediated by a single PXR induction process. Transfection assays. LLC-PK1 cells were plated in 24-well dishes at 2.0 ϫ 10 5 cells per well. Twenty-four hours later, medium was changed and cells transfected with 200 ng of (CYP3A23) 2 -tk-CAT, 66 ng of mPXR and 300 ng of TK-Luciferase by calcium phosphate overnight. The next day, cells were washed once with medium and refed with medium containing 10% charcoal-stripped delipidated calf serum (Sigma) and xenobiotics or steroids. All steroids and xenobiotics were dissolved in dimethyl sulfoxide, with the dimethyl concentration in medium not exceeding 0.1%. Twenty-four hours later, cells were washed once with phosphate-buffered saline and lysed in 100 l of 1ϫ luciferase lysis buffer according to manufacturer's instructions (Promega); 35 l was assayed for luciferase activity and 35 l was assayed for CAT activity as previously described (Burger et al., 1992) . Transfections containing (CYP3A23) 2 -tk-CAT were normalized to TK-luciferase activities. In some cases, BioRad (Richmond, CA) protein assays were performed on 10 l of remaining lysate according to the manufacturer's instructions.
Experimental Procedures

Results
LLC-PK1 cells were chosen for transfection studies because multiple derivative LLC-PK1 cell lines stably expressing a variety of drug and steroid efflux transporters have been made (Schinkel et al., 1995; Evers et al., 1996) . Therefore, if LLC-PK1 cells proved suitable for these transfection studies of PXR, the parent and derivative cell lines could be used in future experiments examining the influence of these transporters on PXR activation. Immunoblot analysis of LLC-PK1 cell lysates with anti-RXR IgG (Affinity Bioreagents) revealed immunodetectable RXR (data not shown). Hybridizable PXR mRNA transcripts were only detectable in lysates of LLC-PK1 cells transfected with the PXR expression vector, but not lysates of nontransfected LLC-PK1 cells (data not shown). We first determined whether PXR could induce the CYP3A23 DR-3 in LLC-PK1 cells treated with established PXR ligands (Kliewer et al., 1998) . Similar to findings in CV-1 cells (Kliewer et al., 1998) , the CYP3A23 DR-3 was induced in LLC-PK1 cells co-transfected with PXR and treated with either dexamethasone-t-butylacetate, RU486, progesterone, 1,16-dimethylpregnenolone, pregnenolone, and 5␤-pregnane-3,20-dione (Fig. 1) , although the fold-increase was not quite as robust as in CV-1 cells. (CYP3A23) 2 -tk-CAT was not transcriptionally activated by these steroids in the absence of co-transfected PXR (data not shown), thus demonstrating PXR's essential role in transactivation by these agents and confirming the original results in CV-1 cells (Kliewer et al., 1998) . Moreover, because neither PXR nor RXR alone can bind to the CYP3A23 DR-3 alone (Kliewer et al., 1998) , but only binds as a heterodimer, the transcriptional activation of the CYP3A23 DR-3 in LLC-PK1 cells further confirms the presence of RXR.
We first tested whether PCBs, previously shown to induce CYP3A23 in rat liver in vivo and in primary rat hepatocytes (Schuetz et al., 1986) , could activate (CYP3A23) 2 -tk-CAT in LLC-PK1 cells co-transfected with PXR. Treatment with various nonplanar polychlorinated biphenyls caused dose-dependent activation of (CYP3A23) 2 -tk-CAT (Fig. 2) , but only in cells co-transfected with PXR (Fig. 4) . Strikingly, except for PCB #47, the rank order of PCB congeners as inducers of (CYP3A23) 2 -tk-CAT was directly associated with the extent of ortho-chlorination, a finding we had shown previously to be correlated with their hierarchy as inducers of the endogenous CYP3A23 gene in rat hepatocyte cultures (Schuetz et al., 1986) . Treatment with 10 M (data not shown) or 20 M of another class of environmental contaminants, the organochlorine pesticides transnonachlor or chlordane (Fig. 4) induced the CYP3A23 DR-3, but only in cells co-transfected with PXR (Fig. 4) . 
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We next determined whether other classes of antihormones besides antiglucocorticoids could use PXR to activate the CYP3A23 DR-3. The antiandrogen cyproterone acetate dose-response curve for CYP3A23 DR-3 activation was similar in potency and efficacy to the glucocorticoid agonist dexamethasone-t-butylacetate (Fig. 3) , whereas the antimineralocorticoid spironolactone was a less efficacious inducer.
For each of the agents not investigated previously (Kliewer et al., 1998) for PXR activation, we compared the activity of (CYP3A23) 2 -tk-CAT in LLC-PK1 cells with or without cotransfected PXR. None of the agents transcriptionally activated (CYP3A23) 2 -tk-CAT in the absence of co-transfected PXR (Fig. 4) or in the presence of co-transfected pSG5 expression vector (Stratagene, LaJolla, CA) substituted for mPXR (data not shown). Importantly, by transfecting cells at a high density (2 ϫ 10 5 /well), we minimized toxic effects of any of the xenobiotics or steroids on cell viability as judged by the recovery of protein per well and trypan blue exclusion. To further control for possible nonspecific effects on the TK promoter, we normalized CAT activity to co-transfected TK-LUC in all experiments (Figs. 1-4) . Because the amount of co-transfected hormone receptor can affect the extent of gene activation (data not shown) we tested the possibility that some of the drugs might produce an increase in PXR expression by activating the simian virus 40 promoter driving PXR expression. However, none of the drugs activated simian virus 40-LUC (PGL2-promoter, Promega, Madison, WI) transfected into LLC-PK1 cells (data not shown). Thus, it is unlikely the level of expressed PXR is affected by these drugs.
Discussion
More than 15 years have passed since it was determined that organochlorine pesticides and PCBs induce CYP3A (Schuetz et al., 1986) . However, the mechanism by which these environmental contaminants up-regulate hepatic CYP3A genes has remained elusive. We had demonstrated previously that these agents induce de novo synthesis of CYP3A23 in primary rat hepatocyte cultures (Schuetz et al., 1986) and postulated that, like dexamethasone and PCN, these agents might induce CYP3A23 synthesis by interacting with the "PCN receptor" (Schuetz et al., 1986) . Our current study identifies PXR, the recently identified receptor activated by PCN, as indispensable in mediating transcriptional activation of the CYP3A23 DR-3 by environmental contaminants such as the nonplanar PCBs. This study also sheds light on the heretofore puzzling finding that many classes of antihormones, in addition to antiglucocorticoids, induce CYP3A (Kocarek et al., 1995) by demonstrating that these steroids activate PXR. Given the high concentrations of steroids and xenobiotics required to activate PXR and the structural and pharmacological diversity among the activators, it is likely that PXR-mediated steroid and xenobiotic activation of CYP3A is primarily for the purpose of metabolizing these foreign molecules.
Both the organochlorine pesticides and the polychlorinated biphenyls are ubiquitous environmental contaminants. We demonstrated previously that nonplanar PCB congeners induced de novo synthesis of CYP3A and induced CYP2B in primary rat hepatocyte cultures and in rat liver in vivo (Schuetz et al., 1986) . Our data herein provide the mechanistic connection demonstrating that these same PCBs use PXR to transcriptionally activate the CYP3A23 DR-3 and, in general, parallel our previous findings. Indeed, it is possible that, in addition to activation of CYP3A, some biological activities of the nonplanar congeners, including toxicities, are mediated by interactions of these PCBs with PXR. PCBs cause liver hypertrophy, are tumor promoters, and cause neurotoxicity and disruptions in calcium regulation (Hansen, 1998) . PXR-mediated PCB activation of the CYP3A23 DR-3 may be a predictive biomarker correlated with some PCB toxicities. Thus, dose-response analysis of PCB congeners or mixtures of PCB for PXR-mediated activation of the CYP3A23 DR-3 may provide an assay to rapidly segregate toxic and nontoxic nonplanar PCBs. Interestingly, the antiandrogen cyproterone acetate, identified herein as a PXR activator, also includes liver cell proliferation, and previous attempts to determine the signaling pathway for proliferation have been futile (Menegazzi et al., 1997) . Cyproterone acetate also causes DNA damage in liver (Werner et al., 1997) , is a rodent liver tumor promoter (Duivenvoorden et al., 1995) , and increases sensitivity of hepatocytes to undergo apoptosis (Oberhammer et al., 1996) . It remains to be determined whether ligand activated PXR is involved in mediating any of these other biological activities associated with nonplanar PCBs or cyproterone acetate.
We conclude that PXR mediates induction of the CYP3A23 DR-3 by antihormones and environmental xenobiotics. Thus, PXR joins the aryl hydrocarbon receptor in being a transcription factor ligand-activated by multiple classes of agents (Nebert, 1989; Dzeletovic et al., 1997) . By analogy to the aryl hydrocarbon receptor paradigm, it will be of interest in the future to determine whether individual differences in PXR ligand affinity among humans correlates with CYP3A inducibility and, like P-glycoprotein (Schuetz et al., 1996) , also contributes to the wide variation in the CYP3A inductive response (Watkins et al., 1989; Kolars et al., 1992) . 
